Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study

BACKGROUND: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. METHODS: In a multicenter, double-blind, randomized study, 229 patients with mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Hiroaki, Iida, Mitsuo, Matsumoto, Takayuki, Suzuki, Yasuo, Sasaki, Hidetaka, Yoshida, Toyomitsu, Takano, Yuichi, Hibi, Toshifumi
Formato: Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972638/
https://www.ncbi.nlm.nih.gov/pubmed/20049950
http://dx.doi.org/10.1002/ibd.21193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972638/
https://www.ncbi.nlm.nih.gov/pubmed/20049950
http://dx.doi.org/10.1002/ibd.21193

Ejemplares similares